178 related articles for article (PubMed ID: 38004431)
1. Neutrophil as a Carrier for Cancer Nanotherapeutics: A Comparative Study of Liposome, PLGA, and Magnetic Nanoparticles Delivery to Tumors.
Garanina AS; Vishnevskiy DA; Chernysheva AA; Valikhov MP; Malinovskaya JA; Lazareva PA; Semkina AS; Abakumov MA; Naumenko VA
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004431
[TBL] [Abstract][Full Text] [Related]
2. Extravasating Neutrophils Open Vascular Barrier and Improve Liposomes Delivery to Tumors.
Naumenko VA; Vlasova KY; Garanina AS; Melnikov PA; Potashnikova DM; Vishnevskiy DA; Vodopyanov SS; Chekhonin VP; Abakumov MA; Majouga AG
ACS Nano; 2019 Nov; 13(11):12599-12612. PubMed ID: 31609576
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-mediated transport is crucial for delivery of short-circulating magnetic nanoparticles to tumors.
Naumenko V; Nikitin A; Garanina A; Melnikov P; Vodopyanov S; Kapitanova K; Potashnikova D; Vishnevskiy D; Alieva I; Ilyasov A; Eletskaya BZ; Abakumov M; Chekhonin V; Majouga A
Acta Biomater; 2020 Mar; 104():176-187. PubMed ID: 31945505
[TBL] [Abstract][Full Text] [Related]
4. Supermagnetic Human Serum Albumin (HSA) Nanoparticles and PLGA-Based Doxorubicin Nanoformulation: A Duet for Selective Nanotherapy.
Malinovskaya J; Salami R; Valikhov M; Vadekhina V; Semyonkin A; Semkina A; Abakumov M; Harel Y; Levy E; Levin T; Persky R; Chekhonin V; Lellouche JP; Melnikov P; Gelperina S
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614071
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-mediated delivery of nanotherapeutics across blood vessel barrier.
Dong X; Chu D; Wang Z
Ther Deliv; 2018 Jan; 9(1):29-35. PubMed ID: 29216803
[TBL] [Abstract][Full Text] [Related]
6. Photosensitization Priming of Tumor Microenvironments Improves Delivery of Nanotherapeutics via Neutrophil Infiltration.
Chu D; Dong X; Zhao Q; Gu J; Wang Z
Adv Mater; 2017 Jul; 29(27):. PubMed ID: 28504320
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection.
Chu D; Gao J; Wang Z
ACS Nano; 2015 Dec; 9(12):11800-11. PubMed ID: 26516654
[TBL] [Abstract][Full Text] [Related]
8. Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia.
Li L; ten Hagen TL; Bolkestein M; Gasselhuber A; Yatvin J; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
J Control Release; 2013 Apr; 167(2):130-7. PubMed ID: 23391444
[TBL] [Abstract][Full Text] [Related]
9. Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition.
Huang R; Fan D; Cheng H; Huo J; Wang S; He H; Zhang G
Int J Nanomedicine; 2023; 18():3359-3375. PubMed ID: 37361388
[TBL] [Abstract][Full Text] [Related]
10. Active targeting liposome-PLGA composite for cisplatin delivery against cervical cancer.
Dana P; Bunthot S; Suktham K; Surassmo S; Yata T; Namdee K; Yingmema W; Yimsoo T; Ruktanonchai UR; Sathornsumetee S; Saengkrit N
Colloids Surf B Biointerfaces; 2020 Dec; 196():111270. PubMed ID: 32777659
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.
Guedj AS; Kell AJ; Barnes M; Stals S; Gonçalves D; Girard D; Lavigne C
Int J Nanomedicine; 2015; 10():5965-79. PubMed ID: 26445538
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil mediated drug delivery for targeted glioblastoma therapy: A comprehensive review.
Hosseinalizadeh H; Mahmoodpour M; Razaghi Bahabadi Z; Hamblin MR; Mirzaei H
Biomed Pharmacother; 2022 Dec; 156():113841. PubMed ID: 36411657
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of acetyl curcumin-loaded core/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications.
Reddy AS; Lakshmi BA; Kim S; Kim J
Eur J Pharm Biopharm; 2019 Sep; 142():518-530. PubMed ID: 31365879
[TBL] [Abstract][Full Text] [Related]
15. Design of hybrid multimodal poly(lactic-co-glycolic acid) polymer nanoparticles for neutrophil labeling, imaging and tracking.
Qiu Y; Palankar R; EcheverrÃa M; Medvedev N; Moya SE; Delcea M
Nanoscale; 2013 Dec; 5(24):12624-32. PubMed ID: 24177321
[TBL] [Abstract][Full Text] [Related]
16. Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization.
Zhang E; Zhukova V; Semyonkin A; Osipova N; Malinovskaya Y; Maksimenko O; Chernikov V; Sokolov M; Grigartzik L; Sabel BA; Gelperina S; Henrich-Noack P
Eur J Pharm Biopharm; 2020 May; 150():131-142. PubMed ID: 32151727
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound-guided delivery of microRNA loaded nanoparticles into cancer.
Wang TY; Choe JW; Pu K; Devulapally R; Bachawal S; Machtaler S; Chowdhury SM; Luong R; Tian L; Khuri-Yakub B; Rao J; Paulmurugan R; Willmann JK
J Control Release; 2015 Apr; 203():99-108. PubMed ID: 25687306
[TBL] [Abstract][Full Text] [Related]
18. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment.
Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H
Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868
[TBL] [Abstract][Full Text] [Related]
19. PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.
Zou P; Stern ST; Sun D
Pharm Res; 2014 Mar; 31(3):684-93. PubMed ID: 24065591
[TBL] [Abstract][Full Text] [Related]
20. Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging.
Rapoport N; Gupta R; Kim YS; O'Neill BE
J Control Release; 2015 May; 206():153-60. PubMed ID: 25776738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
